A GLP-1 blocker acts by inhibiting the GLP-1 receptor, which modulates the downstream inflammatory pathways linked to: cytokine production immune system activation oxidative stress inflammatory signaling in tissues such as the liver, fat cells, and gut In low doses, blocking GLP-1 receptors appears to influence the immune system without significantly interfering with glucose control which is why this approach is being studied specifically for inflammation rather than metabolic disease
Forms Available The most common forms used in injections are cyanocobalamin and hydroxocobalamin, which are synthetic and stable versions of the vitamin
If youve been sidelined by pain, injury, or inflammation, you may have come across two names: BPC-157 and TB-500
Both selenium deficiency and excess increase the risk of infertility due to abnormal sperm motility and viability
While promising, these peptides remain experimental, highlighting the need for further studies to unlock their full potential in regenerative medicine
